The expression of PD-1, PD-L1, and CTLA4 in gastric adenocarcinoma was all higher than in the normal group, with the expression levels of three common immune checkpoints distinctly upregulated in high-risk cohorts. The gene discussed is CTLA4; the disease is gastric adenocarcinoma.